See more : Sensient Technologies Corporation (SXT) Income Statement Analysis – Financial Results
Complete financial analysis of Bullfrog AI Holdings, Inc. Common Stock (BFRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bullfrog AI Holdings, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- St.Shine Optical Co.,Ltd. (1565.TWO) Income Statement Analysis – Financial Results
- Marston’s PLC (MRTPY) Income Statement Analysis – Financial Results
- Thai Oil Public Company Limited (TOIPF) Income Statement Analysis – Financial Results
- Total Access Communication Public Company Limited (DTAC-R.BK) Income Statement Analysis – Financial Results
- Guangdong Tecsun Science & Technology Co.,Ltd. (002908.SZ) Income Statement Analysis – Financial Results
Bullfrog AI Holdings, Inc. Common Stock (BFRG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.bullfrogai.com
About Bullfrog AI Holdings, Inc. Common Stock
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 65.00K | 10.00K | 0.00 | 0.00 |
| Cost of Revenue | 5.20K | 800.00 | 0.00 | 0.00 |
| Gross Profit | 59.80K | 9.20K | 0.00 | 0.00 |
| Gross Profit Ratio | 92.00% | 92.00% | 0.00% | 0.00% |
| Research & Development | 1.43M | 609.27K | 0.00 | 0.00 |
| General & Administrative | 3.99M | 1.86M | 555.36K | 347.19K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.99M | 1.86M | 555.36K | 347.19K |
| Other Expenses | 0.00 | 459.00 | 0.00 | 0.00 |
| Operating Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Cost & Expenses | 5.43M | 2.47M | 555.36K | 347.19K |
| Interest Income | 183.70K | 459.00 | 0.00 | 0.00 |
| Interest Expense | 79.09K | 347.15K | 40.40K | 11.77K |
| Depreciation & Amortization | 1.73K | 1.05K | 236.56K | 206.30K |
| EBITDA | -5.28M | -2.45M | -555.36K | -347.19K |
| EBITDA Ratio | -8,115.47% | -24,542.97% | 0.00% | 0.00% |
| Operating Income | -5.37M | -2.46M | -555.36K | -347.19K |
| Operating Income Ratio | -8,257.73% | -24,558.01% | 0.00% | 0.00% |
| Total Other Income/Expenses | 11.66K | -346.69K | -30.48K | 5.50K |
| Income Before Tax | -5.36M | -2.80M | -585.84K | -341.69K |
| Income Before Tax Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 347.60K | -196.16K | -194.53K |
| Net Income | -5.36M | -2.80M | -585.84K | -341.69K |
| Net Income Ratio | -8,239.80% | -28,024.87% | 0.00% | 0.00% |
| EPS | -0.89 | -0.46 | -0.10 | -0.06 |
| EPS Diluted | -0.89 | -0.46 | -0.10 | -0.06 |
| Weighted Avg Shares Out | 6.05M | 6.09M | 5.65M | 5.65M |
| Weighted Avg Shares Out (Dil) | 6.05M | 6.09M | 5.65M | 5.65M |
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering
BullFrog AI Announces Closing of $5.7 Million Public Offering
WallachBeth Capital Announces Bullfrog AI Pricing of $5.7 Million Public Offering
Bullfrog AI Announces Pricing of $5.7 Million Public Offering
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
Bullfrog AI: advancing technologies in leaps and bounds
Why Is Bullfrog AI (BFRG) Stock Up 30% Today?
This AI stock is up 30% on Wednesday: find out more
BullFrog AI's Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
Source: https://incomestatements.info
Category: Stock Reports